Open access · OA via Europe PMC

Outcomes of Intravitreal Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration in Kazakhstan

Suleimenov M, Kadyrgaliyev B, Kanafyanova E, Meyermanova Z, Abdullina V, Zhankalova Z, Yeshmanova A, Abdykulova A, Almukhambetova S, Kulmaganbetov M.

Vision (Basel, Switzerland) · 2026

Cellular senescence

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: Europe PMC
Canonical: link ↗
Fetched: 2026-10-28 MST

Cite this

APA

M, S., B, K., E, K., Z, M., V, A., Z, Z., A, Y., A, A., S, A., & M., K. (2026). Outcomes of Intravitreal Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration in Kazakhstan. <em>Vision (Basel, Switzerland)</em>. https://europepmc.org/article/PMC/PMC13709814

Vancouver

M S, B K, E K, Z M, V A, Z Z, et al. Outcomes of Intravitreal Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration in Kazakhstan. Vision (Basel, Switzerland). 2026.

BibTeX

@article{suleimenov2026Outcom, title = {Outcomes of Intravitreal Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration in Kazakhstan}, author = {Suleimenov M and Kadyrgaliyev B and Kanafyanova E and Meyermanova Z and Abdullina V and Zhankalova Z and Yeshmanova A and Abdykulova A and Almukhambetova S and Kulmaganbetov M.}, journal = {Vision (Basel, Switzerland)}, year = {2026}, }